Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ATR · against 1,336 other Healthcare companies
Ranked #409 of 1,337 · scores higher than 69% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 60–69, including ATR · Click a bar to see the companies
Mainly thanks to its EBITDA yield, free cash flow yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | ATR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 3.9% | 1.5% | 70% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 7.7% | 4.2% | 72% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 3.6% | -1.0% | 71% | 20% | |
| Book yieldHigher is better · 1,306 reported | 29.0% | 37.9% | 39% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 396 | 25.8B USD | 70 | 75 | |
| 409 | 5.1B CNY (≈$719M) | 69 | 74 | |
| 409 | 225.8B JPY (≈$1.5B) | 69 | 69 | |
| 409 | 2.4B EUR (≈$2.6B) | 69 | 69 | |
| 409 | 9.0B USD | 69 | 57 | |
| 409 | 9.2B USD | 69 | 47 | |
| 409 | 4.8B USD | 69 | 52 | |
| 409 | 154.4B BRL (≈$27.8B) | 69 | 43 | |
| 409 | 1.1B EUR (≈$1.2B) | 69 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score